Related references
Note: Only part of the references are listed.Antimetastatic activities of modified heparins: Selectin inhibition by heparin attenuates metastasis
Lubor Borsig
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2007)
Cancer and thrombosis: from molecular mechanisms to clinical presentations
H. R. Buller et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Platelet glycoprotein Ibα supports experimental lung metastasis
Shashank Jain et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Colon cancer metastasis in mouse liver is not affected by hypercoagulability due to Factor V Leiden mutation
C. P. W. Klerk et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2007)
Heparin attenuates metastasis mainly due to inhibition of P- and L-selectin, but non-anticoagulant heparins can have additional effects
Jennifer L. Stevenson et al.
THROMBOSIS RESEARCH (2007)
Mechanisms of heparin induced anti-cancer activity in experimental cancer models
T. M. H. Niers et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2007)
Role of the factor V Leiden mutation in septic peritonitis assessed in factor V Leiden transgenic mice
Lois W. Bruggemann et al.
CRITICAL CARE MEDICINE (2006)
Experimental metastasis and primary tumor growth in mice with hemophilia A
F Langer et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Role of coagulation FVIII in septic peritonitis assessed in hemophilic mice
SHHF Schoenmakers et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Effect of anticoagulant drugs in cancer
A Falanga et al.
CURRENT OPINION IN PULMONARY MEDICINE (2005)
The effect of low molecular weight heparin on survival in patients with advanced malignancy
CPW Klerk et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Endothelial P-selectin as a target of heparin action in experimental melanoma lung metastasis
RJ Ludwig et al.
CANCER RESEARCH (2004)
Role of endogenous thrombin in tumor implantation, seeding, and spontaneous metastasis
L Hu et al.
BLOOD (2004)
The prothrombotic state in cancer: pathogenic mechanisms
M De Cicco
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2004)
Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: The fragmin advanced malignancy outcome study (FAMOUS)
AK Kakkar et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Atherosclerosis and cancer: common pathways on the vascular endothelium
M Morganti et al.
BIOMEDICINE & PHARMACOTHERAPY (2002)
Impact of thrombophilic gene mutations on thrombosis risk in patients with gastrointestinal carcinoma
R Pihusch et al.
CANCER (2002)
Factor v and thrombotic disease -: Description of a janus-faced protein
GAF Nicolaes et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Resistance to activated protein C, factor V Leiden and the prothrombin G20210A variant in patients with colorectal cancer
GA Paspatis et al.
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2002)
Venous thromboembolism and occult malignancy
HMMB Otten et al.
THROMBOSIS RESEARCH (2001)
Heparin and cancer revisited: Mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis
L Borsig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
